Nuclear cardiology is useful for risk stratification of major cardiac events (MCEs) in Japanese patients with coronary artery disease (CAD). Results of the J-ACCESS study demonstrated that the severity of the summed stress score (SSS) stratifies the risk of future MCEs. A normal SSS predicts a good prognosis and a higher SSS indicates a higher MCE risk. Investigating the association between therapeutic strategy and the risk of MCEs, we demonstrated that revascularization reduces the risk of MCEs in patients with >10% ischemia while optimal medical therapy achieves the same outcome in patients with ≤5% ischemia. We also formulated a risk equation on the basis of evidence obtained from nuclear cardiology to predict the risk of MCEs excluding severe heart failure. In order to benefit from such evidence, it is necessary that expert interpreters precisely evaluate ischemia based on images derived during nuclear cardiology studies. However, automated quantification with total perfusion deficit does not require expert interpreters. We have reported the usefulness of automated quantification with the total perfusion deficit derived from a Japanese normal database in Japanese patients with CAD. Ischemic data obtained from nuclear cardiology are extremely useful for predicting MCEs in patients with CAD. A therapeutic strategy guided by the ischemic data facilitates good medical management with an associated improved prognosis.
with SPECT while medical treatment was effective in patients with <10% ischemia (4). Since there was no such evidence for Japanese patients, we investigated the correlation between therapeutic strategies and prognoses in Japanese patients with stable CAD to determine whether early revascularization affects the incidence of MCEs excluding severe heart failure.
In propensity score-matched patients, the prognosis in the early-revascularization group was similar to that in the noearly-revascularization group. Of those, however, patients with >10% ischemia had a better prognosis and lower MCE rates in the early-revascularization group than in the no-earlyrevascularization group. In contrast, patients with ≤5% ischemia had a better prognosis and lower MCE rates in the no-early-revascularization group than in the earlyrevascularization group (Fig. 1) . According to the above, we concluded that early revascularization may possibly lead to MCEs due to the procedure but may be an effective therapeutic strategy leading to an improved prognosis in patients with moderate to severe ischemia (5). Regarding patients with 6% to 10% ischemia, there was no significant difference in the MCE rate between the earlyrevascularization and no-early-revascularization groups during the three-year follow-up. In such patients with borderline ischemia, risk-stratification with non-invasive fractional flow reserve, which is a physiological ischemic variable derived from coronary computed tomographic angiography, could be used to help determine a therapeutic strategy and could be predictive of prognoses in combination with SPECT. Fig. 2 illustrates typical polar maps obtained in CAD patients with >10% ischemia who had either a good or poor prognosis. The polar maps shown in Fig. 2 
Prediction of MCEs with a risk score
The Heart Risk Table based on nuclear cardiology is a useful tool for estimating the incidence of MCEs, including severe heart failure, in Japanese patients with CAD (8). We conducted a large-scale retrospective prognostic study to come up with a formula that would provide risk scores for MCEs excluding heart failure over a three-year period (9) . The results showed that the factors predicting MCEs were clearly different from those predicting only cardiac death (Table 1) automated quantification when using it in Japanese patients with CAD. The accuracy and reproducibility of automated quantification were comparable to conventional visual quantification. Automated quantification was also confirmed to be useful for prognostic risk stratification of MCEs (13) .
Conclusion
The SSS and stress TPD correctly derived from SPECT images are useful for risk stratification and prediction of MCEs. The SDS and ischemic TPD are useful for determining an effective therapeutic strategy. A therapeutic strategy guided by the ischemic data facilitates good medical management with an associated improved prognosis. The risk score estimated with data obtained from SPECT can be used effectively in daily clinical practice because it is important to be able to explain benefits and risks to patients before deciding a therapeutic strategy.
